Proof of Concept of the Ability of the Kinect to Quantify Upper Extremity Function in Dystrophinopathy

Introduction: Individuals with dystrophinopathy lose upper extremity strength in proximal muscles followed by those more distal. Current upper extremity evaluation tools fail to fully capture changes in upper extremity strength and function across the disease spectrum as they tend to focus solely on distal ability. The Kinect by Microsoft is a gaming interface that can gather positional information about an individual’s upper extremity movement which can be used to determine functional reaching volume, velocity of movement, and rate of fatigue while playing an engaging video game. The purpose of this study was to determine the feasibility of using the Kinect platform to assess upper extremity function in individuals with dystrophinopathy across the spectrum of abilities. Methods: Investigators developed a proof-of-concept device, ACTIVE (Abilities Captured Through Interactive Video Evaluation), to measure functional reaching volume, movement velocity, and rate of fatigue. Five subjects with dystrophinopathy and 5 normal controls were tested using ACTIVE during one testing session. A single subject with dystrophinopathy was simultaneously tested with ACTIVE and a marker-based motion analysis system to establish preliminary validity of measurements. Results: ACTIVE proof-of-concept ranked the upper extremity abilities of subjects with dystrophinopathy by Brooke score, and also differentiated them from performance of normal controls for the functional reaching volume and velocity tests. Preliminary test-retest reliability of the ACTIVE for 2 sequential trials was excellent for functional reaching volume (ICC=0.986, p<0.001) and velocity trials (ICC=0.963, p<0.001). Discussion: The data from our pilot study with ACTIVE proof-of-concept demonstrates that newly available gaming technology has potential to be used to create a low-cost, widely-accessible and functional upper extremity outcome measure for use with children and adults with dystrophinopathy.

[1]  T. Voit,et al.  Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients , 2013, Neuromuscular Disorders.

[2]  J B Carlin,et al.  Reliability of the Melbourne assessment of unilateral upper limb function. , 2001, Developmental medicine and child neurology.

[3]  Clifford Qualls,et al.  Measuring dexterity in children using the Nine-hole Peg Test. , 2005, Journal of hand therapy : official journal of the American Society of Hand Therapists.

[4]  Jingzhou Yang,et al.  Towards understanding the workspace of human limbs , 2004, Ergonomics.

[5]  S. Phillips,et al.  Fatigue Impact Scale Demonstrates Greater Fatigue in Younger Stroke Survivors , 2012, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[6]  Catherine Klersy,et al.  Quality of Life in Duchenne Muscular Dystrophy: The Subjective Impact on Children and Parents , 2011, Journal of child neurology.

[7]  Jean-Louis Thonnard,et al.  ACTIVLIM: A Rasch-built measure of activity limitations in children and adults with neuromuscular disorders , 2007, Neuromuscular Disorders.

[8]  Fabiana Luisa Mattar,et al.  Hand weakness in Duchenne muscular dystrophy and its relation to physical disability , 2008, Neuromuscular Disorders.

[9]  Clark C. Presson,et al.  Normative and Validation Studies of the Nine-Hole Peg Test with Children , 2000, Perceptual and motor skills.

[10]  A. Mahon,et al.  Perceived Exertion , 2006, Sports medicine.

[11]  R. Abresch,et al.  Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease , 2002, The American journal of hospice & palliative care.

[12]  K. Davies,et al.  Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  Ruzena Bajcsy,et al.  Development and Application of Stereo Camera-Based Upper Extremity Workspace Evaluation in Patients with Neuromuscular Diseases , 2012, PloS one.

[14]  Krista Vandenborne,et al.  Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health , 2012, Health and Quality of Life Outcomes.

[15]  A. Pressler,et al.  Associations between Borg’s rating of perceived exertion and physiological measures of exercise intensity , 2012, European Journal of Applied Physiology.

[16]  R. H. Jebsen,et al.  An objective and standardized test of hand function. , 1969, Archives of physical medicine and rehabilitation.

[17]  A. Geurts,et al.  Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study , 2010, BMC pediatrics.

[18]  C. Hulme,et al.  PERCEPTUAL JUDGEMENTS OF NORMAL AND CLUMSY CHILDREN , 1987, Developmental medicine and child neurology.

[19]  J. Miller,et al.  Clinical investigation in duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history , 1983, Muscle & nerve.

[20]  Jay J. Han,et al.  The 6‐minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observations , 2010, Muscle & nerve.

[21]  Jau-Shin Lou,et al.  Assessment and Management of Fatigue in Neuromuscular Disease , 2010, The American journal of hospice & palliative care.

[22]  Jay J. Han,et al.  The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy , 2010, Muscle & nerve.

[23]  L. Køber,et al.  Endurance training improves fitness and strength in patients with Becker muscular dystrophy. , 2008, Brain : a journal of neurology.

[24]  S Lyager,et al.  Indicators of need for mechanical ventilation in Duchenne muscular dystrophy and spinal muscular atrophy. , 1995, Chest.

[25]  E. Mazzone,et al.  A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy , 2012, Developmental medicine and child neurology.

[26]  M A Robinson,et al.  Analysis of tetraplegic reaching in their 3D workspace following posterior deltoid-triceps tendon transfer , 2010, Spinal Cord.

[27]  Louise R. Rodino-Klapac,et al.  Update on the Treatment of Duchenne Muscular Dystrophy , 2013, Current Neurology and Neuroscience Reports.

[28]  C. Häger-Ross,et al.  Hand function in Charcot Marie Tooth: test retest reliability of some measurements , 2006, Clinical rehabilitation.

[29]  Jay J. Han,et al.  Percent-Predicted 6-Minute Walk Distance in Duchenne Muscular Dystrophy to Account for Maturational Influences , 2012, PLoS currents.

[30]  M A Province,et al.  Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls. , 1987, Archives of neurology.

[31]  A L Hull,et al.  Assessment of hand function in Duchenne muscular dystrophy. , 1993, Archives of physical medicine and rehabilitation.

[32]  W M Fowler,et al.  Upper extremity functional rating for patients with Duchenne muscular dystrophy. , 1987, Archives of physical medicine and rehabilitation.

[33]  U.D. Croce,et al.  Surface-marker cluster design criteria for 3-D bone movement reconstruction , 1997, IEEE Transactions on Biomedical Engineering.